nach oben

Erschienen in:

24.03.2016 | Neuro

Brain parenchymal damage in neuromyelitis optica spectrum disorder – A multimodal MRI study

verfasst von: F. Pache, H. Zimmermann, C. Finke, A. Lacheta, S. Papazoglou, J. Kuchling, J. Wuerfel, B. Hamm, K. Ruprecht, F. Paul, A. U. Brandt, M. Scheel

Erschienen in: European Radiology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate different brain regions for grey (GM) and white matter (WM) damage in a well-defined cohort of neuromyelitis optica spectrum disorder (NMOSD) patients and compare advanced MRI techniques (VBM, Subcortical and cortical analyses (Freesurfer), and DTI) for their ability to detect damage in NMOSD.

Methods

We analyzed 21 NMOSD patients and 21 age and gender matched control subjects. VBM (GW/WM) and DTI whole brain (TBSS) analyses were performed at different statistical thresholds to reflect different statistical approaches in previous studies. In an automated atlas-based approach, Freesurfer and DTI results were compared between NMOSD and controls.

Results

DTI TBSS and DTI atlas based analysis demonstrated microstructural impairment only within the optic radiation or in regions associated with the optic radiation (posterior thalamic radiation p < 0.001, 6.9 % reduction of fractional anisotropy). VBM demonstrated widespread brain GM and WM reduction, but only at exploratory statistical thresholds, with no differences remaining after correction for multiple comparisons. Freesurfer analysis demonstrated no group differences.

Conclusion

NMOSD specific parenchymal brain damage is predominantly located in the optic radiation, likely due to a secondary degeneration caused by ON. In comparison, DTI appears to be the most reliable and sensitive technique for brain damage detection in NMOSD.

Key Points

• The hypothesis of a widespread brain damage in NMOSD is challenged.

• The optic radiation (OR) is the most severely affected region.

• OR-affection is likely due to secondary degeneration following optic neuritis.

• DTI is currently the most sensitive technique for NMOSD-related brain-damage detection.

• DTI is currently the most reliable technique for NMOSD-related brain-damage detection.

Nur mit Berechtigung zugänglich

Kim HJ, Paul F, Lana-Peixoto MA et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84:1165–1173CrossRefPubMedPubMedCentral

Jarius S, Wildemann B, Paul F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149–164CrossRefPubMedPubMedCentral

Filippi M, Rocca MA, Moiola L et al (1999) MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology 53:1705–1705CrossRefPubMed

Rocca MA, Agosta F, Mezzapesa DM et al (2004) Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 62:476–478CrossRefPubMed

Yu CS, Lin FC, Li KC et al (2006) Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am J Neuroradiol 27:1009–1015PubMed

Yu C, Lin F, Li K et al (2008) Pathogenesis of Normal-appearing White Matter Damage in Neuromyelitis Optica: Diffusion-Tensor MR Imaging. Radiology 246:222–228CrossRefPubMed

Bichuetti DB, Rivero RLM, de Oliveira EML et al (2008) White matter spectroscopy in neuromyelitis optica: a case control study. J Neurol 255:1895–1899CrossRefPubMed

Aboul-Enein F, Krssák M, Höftberger R et al (2010) Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol 31:76–79CrossRefPubMed

de Seze J, Blanc F, Kremer S et al (2010) Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry 81:409–411CrossRefPubMed

10.

Calabrese M, Oh MS, Favaretto A et al (2012) No MRI evidence of cortical lesions in neuromyelitis optica. Neurology 79:1671–1676CrossRefPubMed

11.

Rueda Lopes FC, Doring T, Martins C et al (2012) The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study. Radiology 263:235–242CrossRefPubMed

12.

Zhao D-D, Zhou H-Y, Wu Q-Z et al (2012) Diffusion tensor imaging characterization of occult brain damage in relapsing neuromyelitis optica using 3.0T magnetic resonance imaging techniques. NeuroImage 59:3173–3177CrossRefPubMed

13.

Jeantroux J, Kremer S, Lin XZ et al (2012) Diffusion tensor imaging of normal-appearing white matter in neuromyelitis optica. J Neuroradiol J Neuroradiol 39:295–300CrossRefPubMed

14.

Liu Y, Duan Y, He Y et al (2012) A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler Houndmills Basingstoke Engl 18:1013–1021CrossRef

15.

Pichiecchio A, Tavazzi E, Poloni G et al (2012) Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler Houndmills Basingstoke Engl 18:817–824CrossRef

16.

Duan Y, Liu Y, Liang P et al (2012) Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study. Eur J Radiol 81:e110–e114CrossRefPubMed

17.

Blanc F, Noblet V, Jung B et al (2012) White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS One 7:e33878CrossRefPubMedPubMedCentral

18.

Chanson J-B, Lamy J, Rousseau F et al (2013) White matter volume is decreased in the brain of patients with neuromyelitis optica. Eur J Neurol 20:361–367CrossRefPubMed

19.

Kimura MCG, Doring TM, Rueda FC et al (2014) In vivo assessment of white matter damage in neuromyelitis optica: a diffusion tensor and diffusion kurtosis MR imaging study. J Neurol Sci 345:172–175CrossRefPubMed

20.

von Glehn F, Jarius S, Cavalcanti Lira RP et al (2014) Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Mult Scler. doi:10.1177/1352458513519838

21.

Doring TM, Lopes FCR, Kubo TTA et al (2014) Neuromyelitis optica: a diffusional kurtosis imaging study. AJNR Am J Neuroradiol 35:2287–2292CrossRefPubMed

22.

Duan Y, Liu Y, Liang P et al (2014) White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study. Acta Radiol 55:589–593CrossRefPubMed

23.

Lopes FCR, Alves-Leon SV, Godoy JM et al (2015) Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI. J Neuroimaging Off J Am Soc Neuroimaging. doi:10.1111/jon.12191

24.

Kremer S, Renard F, Achard S et al (2015) Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol 72:815–822CrossRefPubMedPubMedCentral

25.

Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflammation 10:8PubMedPubMedCentral

26.

Jarius S, Paul F, Franciotta D et al (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202–214PubMed

27.

Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed

28.

Lennon VA, Kryzer TJ, Pittock SJ et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477CrossRefPubMedPubMedCentral

29.

Metz I, Beißbarth T, Ellenberger D et al (2016) Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2016;3:e204

30.

Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489CrossRefPubMed

31.

Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189CrossRefPubMedPubMedCentral

32.

Kister I, Paul F (2015) Pushing the boundaries of neuromyelitis optica: does antibody make the disease? Neurology 85:118–119CrossRefPubMed

33.

Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 9:14CrossRefPubMedPubMedCentral

34.

Cabrera-Gómez JA, Quevedo-Sotolongo L, González-Quevedo A et al (2007) Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler Houndmills Basingstoke Engl 13:186–192CrossRef

35.

Li Y, Xie P, Lv F et al (2008) Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 118:218–225CrossRefPubMed

36.

Matthews L, Marasco R, Jenkinson M et al (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 80:1330–1337CrossRefPubMedPubMedCentral

37.

Sinnecker T, Dörr J, Pfueller CF et al (2012) Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79:708–714CrossRefPubMed

38.

Kister I, Herbert J, Zhou Y, Ge Y (2013) Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica. Mult Scler Int 2013:398259PubMedPubMedCentral

39.

Pittock SJ, Lennon VA, Krecke K et al (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390–396CrossRefPubMed

40.

Tackley G, Kuker W, Palace J (2014) Magnetic resonance imaging in neuromyelitis optica. Mult Scler J 20:1153–1164CrossRef

41.

Chan K, Tse CT, Chung CP et al (2011) Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol 68:1432–1439CrossRefPubMed

42.

He D, Wu Q, Chen X et al (2011) Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse. Brain Cogn 77:80–88CrossRefPubMed

43.

Rocca MA, Parisi L, Pagani E et al (2014) Regional but not global brain damage contributes to fatigue in multiple sclerosis. Radiology 273:511–520CrossRefPubMed

44.

Rueda Lopes FC, Doring T, Martins C et al (2012) The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study. Radiology 263:235–242CrossRefPubMed

45.

de Seze J, Blanc F, Kremer S et al (2010) Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry 81:409–411CrossRefPubMed

46.

Yu CS, Zhu CZ, Li KC et al (2007) Relapsing Neuromyelitis Optica and Relapsing-Remitting Multiple Sclerosis: Differentiation at Diffusion-Tensor MR Imaging of Corpus Callosum 1. Radiology 244:249–256CrossRefPubMed

47.

Wingerchuk DM, Lennon VA, Lucchinetti CF et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815CrossRefPubMed

48.

Dalmau J (2015) Observations on the evolving fields of neuroimmunology and neuroinflammation. Neurol Neuroimmunol Neuroinflammation 2:e67CrossRef

49.

Kitley J, Leite MI, Nakashima I et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain J Neurol 135:1834–1849CrossRef

50.

Ashburner J (2007) A fast diffeomorphic image registration algorithm. NeuroImage 38:95–113CrossRefPubMed

51.

Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97:11050–11055CrossRefPubMedPubMedCentral

52.

Desikan RS, Ségonne F, Fischl B et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31:968–980CrossRefPubMed

53.

Fischl B, Salat DH, Busa E et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355CrossRefPubMed

54.

Fischl B (2012) FreeSurfer. NeuroImage 62:774–781CrossRefPubMedPubMedCentral

55.

Jenkinson M, Beckmann CF, Behrens TEJ et al (2012) FSL. NeuroImage 62:782–790CrossRefPubMed

56.

Smith SM, Jenkinson M, Johansen-Berg H et al (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31:1487–1505CrossRefPubMed

57.

Oberwahrenbrock T, Ringelstein M, Jentschke S et al (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler 19:1887–1895CrossRefPubMed

58.

Tewarie P, Balk L, Costello F et al (2012) The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment. PLoS One 7:e34823CrossRefPubMedPubMedCentral

59.

Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 44:83–98CrossRefPubMed

60.

Højsgaard S, Halekoh U, Yan J (2006) The R Package geepack for Generalized Estimating Equations. J Stat Softw 15(2):1–11

61.

Gabilondo I, Martínez-Lapiscina EH, Fraga-Pumar E et al (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77:517–528CrossRefPubMed

62.

Sinnecker T, Oberwahrenbrock T, Metz I et al (2015) Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study. Eur Radiol 25:122–131CrossRefPubMed

63.

Pfueller CF, Brandt AU, Schubert F et al (2011) Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One 6:e18019CrossRefPubMedPubMedCentral

64.

Popescu BFG, Parisi JE, Cabrera-Gómez JA et al (2010) Absence of cortical demyelination in neuromyelitis optica. Neurology 75:2103–2109CrossRefPubMedPubMedCentral

65.

Simó M, Rifà-Ros X, Rodriguez-Fornells A, Bruna J (2013) Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev 37:1311–1321CrossRefPubMed

Titel: Brain parenchymal damage in neuromyelitis optica spectrum disorder – A multimodal MRI study
verfasst von: F. Pache
H. Zimmermann
C. Finke
A. Lacheta
S. Papazoglou
J. Kuchling
J. Wuerfel
B. Hamm
K. Ruprecht
F. Paul
A. U. Brandt
M. Scheel
Publikationsdatum: 24.03.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 12/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-016-4282-x

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Brain parenchymal damage in neuromyelitis optica spectrum disorder – A multimodal MRI study

Abstract

Objective

Methods

Results

Conclusion

Key Points

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Key Points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2016

Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest

Does size reliably predict malignancy in soft tissue tumours?

Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study

The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer

The predictive value of preoperative 18F-fluorodeoxyglucose PET for postoperative recurrence in patients with localized primary gastrointestinal stromal tumour

Clinical significance of post-treatment 18F-fluorodeoxyglucose uptake in cervical lymph nodes in patients with diffuse large B-cell lymphoma

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie